Capabilities · Sterile products & aseptic filling

Oil-based vial injections

A proposed service scope for oil-based injectable presentations, connecting product-specific compounding, material viscosity considerations, appropriate vial filling, container closure and visual inspection.

PlannedInitial project scope

Illustrative unbranded vial neck and filling nozzle detail.
Illustrative unbranded vial neck and filling nozzle detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Initial project scope

Status
PlannedNo available service asserted
Source-plan relationship
Initial project scopeDocumented in the 15 June 2026 project plan
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

The catalogue identifies oil-based vial injection as a planned service domain. The exact formulation, vehicle nature and intended technical route would define its specific processing scope.

The initial formulation-and-filling plan identifies a presentation for oil-based injection in a 10 mL vial alongside other sterile formats. The proposed catalogue establishes a framework for technical discussion.

Viscous formulations introduce distinct compounding and filtration variables compared with aqueous liquids. Process design would need to account for line clearance, temperature requirements, material compatibility and fill-weight accuracy across the batch.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
10 mL oil-based vialsOil-based injection in a 10 mL vial identified in the source plan.Initial project scopePlanned
Smaller volume oil-based injectionsVolumes differing from the initial plan would require separate technical and process evaluation.Catalogue scopePlanned
Aseptic filling of vialsAseptic filling of vialsProposed broader vial format scope not restricted to oil-based formulations.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Material characterisation & preparation

Assess the physical properties of the vehicle, raw materials and required compounding temperatures.

02 · Process stage

Planned

Compounding & mixing controls

Define the mixing sequence, thermal controls and dissolution parameters necessary for homogeneous formulation.

03 · Process stage

Planned

Filtration assessment

Evaluate appropriate filter membranes, pressure requirements and temperature controls for viscous liquid sterilisation.

04 · Process stage

Planned

Filling & closure operations

Consider specific pump mechanics, line speeds and stoppering techniques suitable for non-aqueous presentations.

05 · Process stage

Planned

Visual inspection parameters

Establish specific inspection criteria to identify particulates or defects within a dense fluid.

06 · Process stage

Planned

Testing & batch disposition

Connect the analytical results, process execution records and accountable review decisions for disposition.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedInitial project scope

Aseptic filling of vials

Product preparation, filling, closure and visual-inspection scope.

Explore proposed scope

02PlannedCatalogue scope

Container-closure integrity testing

Presentation-specific integrity questions and the supporting method.

Explore proposed scope

03PlannedCatalogue scope

Preformulation & formulation development

Material properties, formulation options and product-specific development questions.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Formulation properties
Detailed viscosity, thermal stability and solubility data for the proposed product.
Facility suitability
Appropriate installed equipment and qualification for handling oil-based vehicles.
Process parameters
Defined compounding sequences, filtration limits and filling accuracy evidence.
Quality responsibilities
Clear demarcation of analytical scope, documentation control and review rights.
Regulatory alignment
Applicable permissions for manufacturing and handling the specific formulation.
Technical agreement
Responsibilities, scope and procedural boundaries for the intended technical work.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating oil-based injection service.

Does the initial plan include all oil volumes?

No. The initial plan identifies a 10 mL oil-based vial presentation. Other volumes or container types would require separate evaluation and scope confirmation.

What information helps define the question?

Identify the exact formulation, vehicle properties, desired presentation, development stage and intended destination. Confidential data should only be shared through an agreed secure route.

Is there a service launch quarter?

No. No service-specific quarter is established. Project-wide indicative milestones do not commit any individual technical service to a start date.

Does a technical discussion establish supply?

No. Feasibility, equipment suitability, permissions, evidence generation and formal agreement would need to be established before any service commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma